Sign Up to like & get recommendations! 0
Published in 2020 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-020-01199-4
Abstract: Graves’ orbitopathy (GO) is believed to reflect an autoimmune aggression against antigens expressed by thyroid epithelial cells and orbital fibroblasts [1]. We report a case of de novo appearance of Graves’ hyperthyroidism (GH) and GO… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000031042
Abstract: Rationale: Pancytopenia and epilepsia are rare complications of Graves’ disease (GD). Muscle weakness is a physical sign of GD. It is extremely rare for GD patients to present 3 symptoms at the same time. Patient… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Archives of Disease in Childhood"
DOI: 10.1136/archdischild-2021-323049
Abstract: CLINICAL SCENARIO A 14yearold female attends the paediatric Emergency Department with noticeable palpitations, tremor and debilitating headache. On observations, she was found to have a heart rate of 112 bpm and a blood pressure of… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "European Thyroid Journal"
DOI: 10.1159/000479629
Abstract: Background: Graves’ orbitopathy (GO) is believed to be the consequence of autoimmunity against antigens that are present both in the thyroid and orbital tissues. Massive release of thyroid antigens causes the appearance or deterioration of… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "European Thyroid Journal"
DOI: 10.1159/000490384
Abstract: Graves’ disease (GD) is a systemic autoimmune disorder characterized by the infiltration of thyroid antigen-specific T cells into thyroid-stimulating hormone receptor (TSH-R)-expressing tissues. Stimulatory autoantibodies (Ab) in GD activate the TSH-R leading to thyroid hyperplasia… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Clinical Diabetes and Endocrinology"
DOI: 10.1186/s40842-018-0054-7
Abstract: BackgroundGraves’ hyperthyroidism affects 0.2% of pregnant women. Establishing the correct diagnosis and effectively managing Graves’ hyperthyroidism in pregnancy remains a challenge for physicians.MainThe goal of this paper is to review the diagnosis and management of… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Endocrine journal"
DOI: 10.1507/endocrj.ej18-0418
Abstract: Since there have been few reports on the long-term prognosis of Graves' hyperthyroidism, the prognosis of 549 Graves' hyperthyroidism patients initially treated with thionamide and followed for >8 (range: 8.6-36.4) years was studied, evaluating the… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "European Thyroid Journal"
DOI: 10.1530/etj-22-0031
Abstract: Purpose In this prospective multicenter study with patients newly diagnosed with Graves’ hyperthyroidism (GH), we studied the timing and characteristics of adverse drug reactions in patients treated with anti-thyroid drugs (ATD) for up to 48… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "European Thyroid Journal"
DOI: 10.1530/etj-22-0226
Abstract: Objective This study evaluated the efficacy of antithyroid drugs (ATDs) and risk factors associated with the recurrence of Graves’ hyperthyroidism using a comprehensive retrospective cohort. Methods We included 1829 patients newly diagnosed with Graves’ hyperthyroidism,… read more here.